Association of blood biomarkers and autoimmunity with immune related adverse events in patients with cancer treated with immune checkpoint inhibitors

Patients with cancer treated with immune checkpoint inhibitors (ICIs) develop immune related adverse events (irAEs), however biomarkers are lacking. We hypothesized that clinicopathologic and laboratory factors would be associated with irAE risk and overall survival (OS) in this population. In a ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Michailidou, Despina, Khaki, Ali Raza, Morelli, Maria Pia, Diamantopoulos, Leonidas, Singh, Namrata, Grivas, Petros
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079370/
https://www.ncbi.nlm.nih.gov/pubmed/33907229
http://dx.doi.org/10.1038/s41598-021-88307-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079370/
https://www.ncbi.nlm.nih.gov/pubmed/33907229
http://dx.doi.org/10.1038/s41598-021-88307-3

Ejemplares similares